Sana Biotechnology, Inc. (SANA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.03B |
| Enterprise Value | 1.04B |
| P/E Ratio | -5.14 |
| PEG Ratio | -0.15 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.48 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.5 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.49 |
| Return On Equity | -1.34 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -12.75M |
| EBITDA | -231.42M |
| Net Income | -244.17M |
| Diluted EPS | -0.96 |
Balance Sheet
| Total Cash | 160.49M |
| Total Cash/Share | 0.54 |
| Total Debt | 73.74M |
| Total Debt/Equity | 0.48 |
| Current Ratio | 1.38 |
| Book Value Per Share | 0.52 |
Price History
| 52-Week Change | 9.22 |
| 52-Week High | 6.55 |
| 52-Week Low | 2.61 |
| Moving Average 50 Days | 3.44 |
| Moving Average 200 Days | 3.7 |
Statistics
| Average Volume | 3.28M |
| Shares Outstanding | 278.29M |
| % Held by Institutions | 67.09 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
